{
    "data": [
        {
            "id": "69a0398324c37e0001bb3f95",
            "title": "Nuveen Churchill Direct: Q4 Earnings Insights",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Nuveen Churchill Direct</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/NCDL\" target=\"_blank\">NCDL</a>) just disclosed its Q4 earnings on Thursday, February 26, 2026 at 07:15 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a brief overview of the earnings report.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Nuveen Churchill Direct beat estimated earnings by 2.33%, reporting an EPS of $0.44 versus an estimate of $0.43.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was down $7.04 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Analysis of Past Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Last quarter the company missed on EPS by $0.03 which was followed by a 0.91% drop in the share price the next day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Nuveen Churchill Direct's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for Nuveen Churchill Direct <a href=\"https://www.benzinga.com/quote/NCDL/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_7.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50883027/nuveen-churchill-direct-q4-earnings-insights",
            "pub_date": "2026-02-26 20:16:07",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a039fb24c37e0001bb3fe9",
            "title": "ACM Research Q4 Earnings Report: What Investors Need to Know",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>ACM Research</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ACMR\" target=\"_blank\">ACMR</a>) reported its Q4 earnings results on Thursday, February 26, 2026 at 07:00 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's what investors need to know about the announcement.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">ACM Research missed estimated earnings by -26.47%, reporting an EPS of $0.25 versus an estimate of $0.34.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was up $20.96 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Performance in Previous Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">During the previous quarter, the company missed on EPS by $0.09, leading to a 0.71% drop share price change the next day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at ACM Research's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for ACM Research <a href=\"https://www.benzinga.com/quote/ACMR/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_8.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50883109/acm-research-q4-earnings-report-what-investors-need-to-know",
            "pub_date": "2026-02-26 20:18:07",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a0390b24c37e0001bb3f29",
            "title": "Aclaris Therapeutics Q4 Earnings Summary &amp; Key Takeaways",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Aclaris Therapeutics</strong> (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/ACRS\" target=\"_blank\">ACRS</a>) reported its Q4 earnings results on Thursday, February 26, 2026 at 06:58 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's what investors need to know about the announcement.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Aclaris Therapeutics missed estimated earnings by -14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was down $7.92 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Analysis of Past Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">During the previous quarter, the company beat on EPS by $0.02, leading to a 2.2% increase share price change the next day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Aclaris Therapeutics's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for Aclaris Therapeutics <a href=\"https://www.benzinga.com/quote/ACRS/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50882925/aclaris-therapeutics-q4-earnings-summary-key-takeaways",
            "pub_date": "2026-02-26 20:14:06",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a0391e24c37e0001bb3f44",
            "title": "What&#39;s Going On With CrowdStrike Stock Thursday?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>CrowdStrike Holdings, Inc.</strong> <a href=\"https://www.benzinga.com/quote/CRWD\" rel=\"noreferrer noopener\" target=\"_blank\"></a><a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"CRWD\" href=\"https://www.benzinga.com/quote/CRWD\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/CRWD\" target=\"_blank\">CRWD</a>)<!-- --> shares are down during Thursday’s premarket session.</p><!--/$--><!--$--><p class=\"block core-block\">VAST Data announced a new partnership with CrowdStrike to <a href=\"https://www.benzinga.com/pressreleases/26/02/b50862201/vast-data-and-crowdstrike-partner-to-establish-a-unified-security-model-for-the-ai-lifecycle\" rel=\"noreferrer noopener\" target=\"_blank\">improve security</a> for companies using artificial intelligence.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Details</h2><!--/$--><!--$--><p class=\"block core-block\">The partnership integrates VAST’s data-layer governance with CrowdStrike’s enterprise-grade threat detection, aiming to secure the entire AI lifecycle, from data ingestion to operational deployment.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>George Kurtz</strong>, CEO of CrowdStrike, emphasized the importance of this collaboration, stating, “AI is becoming the operating system of the modern enterprise,” highlighting the need for robust security measures at the data layer.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">As enterprises transition from AI experimentation to production, the partnership seeks to address evolving risks associated with continuous data ingestion and dynamic workflows.</p><!--/$--><!--$--><p class=\"block core-block\">This initiative is expected to bolster security for AI systems, enabling organizations to deploy production AI with greater confidence.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Technical Analysis</h2><!--/$--><!--$--><p class=\"block core-block\">The stock is currently trading 12.5% below its 20-day simple moving average (SMA) and 20.3% below its 100-day SMA, indicating a bearish trend in the short to medium term. Over the past 12 months, shares have decreased significantly, and they are currently positioned closer to their 52-week lows than highs, suggesting ongoing weakness in the stock’s performance.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The RSI is at 44.45, which is considered neutral territory, while the MACD is at 0.15, below its signal line at 0.22, indicating bearish pressure on the stock. The combination of neutral RSI and bearish MACD suggests mixed momentum, reflecting uncertainty in the stock’s near-term outlook.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Key Resistance</strong>: $375.00</li>\n<li><strong>Key Support</strong>: $298.00</li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\">Earnings &amp; Analyst Outlook</h2><!--/$--><!--$--><p class=\"block core-block\">The countdown is on: CRWD is set to report earnings on March 3, 2026.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>EPS Estimate</strong>: 74 cents (Down from $1.03)</li>\n<li><strong>Revenue Estimate</strong>: $1.30 billion (Up from $1.06 billion)</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Consensus &amp; Recent Actions:</strong> The stock carries a Buy Rating with an <a href=\"https://www.benzinga.com/quote/NASDAQ:CRWD/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">average price target</a> of $549.00. Recent analyst moves include:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Evercore ISI Group</strong>: In-Line (Lowers Target to $375.00) (Feb. 25)</li>\n<li><strong>TD Cowen</strong>: Buy (Lowers Target to $480.00) (Feb. 24)</li>\n<li><strong>Oppenheimer</strong>: Outperform (Lowers Target to $500.00) (Feb. 24)</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>CRWD Price Action:</strong> CrowdStrike Holdings shares were down 0.79% at $360.45 during premarket trading on Thursday, according to <a href=\"https://pro.benzinga.com/dashboard\" rel=\"noreferrer noopener\" target=\"_blank\">Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo by IgorGolovniov via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50882952\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/26/CrowdStrike-Extends-Strength.jpeg",
            "link": "https://www.benzinga.com/markets/large-cap/26/02/50882952/whats-going-on-with-crowdstrike-stock-thursday",
            "pub_date": "2026-02-26 20:14:25",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a0382424c37e0001bb3e19",
            "title": "Insights into Ardagh Metal Packaging Q4 Earnings",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">The earnings results for <strong>Ardagh Metal Packaging</strong> (NYSE:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/AMBP\" target=\"_blank\">AMBP</a>) for Q4 were made public on Thursday, February 26, 2026 at 07:00 AM.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a comprehensive overview of the announcement.</p><!--/$--><!--$--><h3 class=\"block core-block\">Earnings</h3><!--/$--><!--$--><p class=\"block core-block\">Ardagh Metal Packaging beat estimated earnings by 50.0%, reporting an EPS of $0.03 versus an estimate of $0.02.</p><!--/$--><!--$--><p class=\"block core-block\">Revenue was up $151.00 million from the same period last year.</p><!--/$--><!--$--><h3 class=\"block core-block\">Previous Earnings Records</h3><!--/$--><!--$--><p class=\"block core-block\">The company beat on EPS by $0.01 in the last quarter, resulting in a 5.72% drop share price change the following day.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at Ardagh Metal Packaging's past performance:</p><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">To track all earnings releases for Ardagh Metal Packaging <a href=\"https://www.benzinga.com/quote/AMBP/earnings\" target=\"_blank\">visit their earnings calendar here.</a> </p><!--/$--><!--$--><p class=\"block core-block\">This article was generated by Benzinga's automated content engine and reviewed by an editor.</p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/analyst_ratings_6.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50882653/insights-into-ardagh-metal-packaging-q4-earnings",
            "pub_date": "2026-02-26 20:10:15",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}